Anti-mullerian hormone: Clinical relevance in assisted reproductive therapy

Annales d'Endocrinologie

Volumn 67, Issue 6, 2006, Pages 567-574

  Freour T ^a   Mirallie S ^a   Colombel, A ^a   Bach Ngohou, K ^a   Masson, D ^a   Barriere P ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Anti Mullerian hormone; Ovarian reserve

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; GONAD; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MALE; OVARY FUNCTION; PREDICTOR VARIABLE; PREGNANCY; REPRODUCTION; REVIEW;

EID: 33845944093     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(06)73008-6     Document Type: Review

References (49)

1. Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003 ; 18 : 2368-74.
2. Belville C, Van Vlijmen H, Ehrenfels C et al. Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model. Mol Endocrinol 2004 ; 18 : 708-21.
3. Chu MC, Carmina E, Wang J, Lobo RA. Mullerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B. Fertil Steril 2005 ; 84 : 1685-8.
4. Cook CL, Siow Y, Brenner AG, Fallat ME. Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril 2002 ; 77 : 141-6.
5. Cook CL, Siow Y, Taylor S, Fallat ME. Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 2000 ; 73 : 859-61.
6. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Anti-mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002 ; 77 : 357-62.
7. Deffieux X and JM Antoine. Inhibins, activins and anti-Mullerian hormone: structure, signalling pathways, roles and predictive value in reproductive medicine. Gynecol Obstet Fertil 2003 ; 31 : 900-11.
8. di Clemente N, Josso N, Gouedard L, Belville C. Components of the anti-Mullerian hormone signaling pathway in gonads. Mol Cell Endocrinol 2003 ; 211 : 9-14.
9. Durlinger AL, Gruijters MJ, Kramer P et al. Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001 ; 142 : 4891-9.
10. Durlinger AL, Kramer P, Karels B et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 1999 ; 140 : 5789-96.
11. Eldar-Geva T, Margalioth EJ, Gal M et al. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod 2005 ; 20 : 1814-9.
12. Eldar-Geva T , Ben Chetrit A , Spitz IM et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod 2005 ; 20 : 3178-83.
13. Fanchin R, Schonauer LM, Righini C et al. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003 ; 18 : 323-7.
14. Ficicioglu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril 2006 ; 85 : 592-6.
15. Fréour T, Mirallié S, Bach-Ngohou K, Denis M, Barrière P, Masson D. Measurement of serum Anti-Müllerian Hormone by Beckman Coulter ELISA and DSL ELISA : comparison and relevance in ART. Clin Chim Acta 2006 ; in press.
16. Gruijters MJ, Visser JA, Durlinger AL, Themmen AP. Anti-Mullerian hormone and its role in ovarian function. Mol Cell Endocrinol 2003 ; 211 : 85-90.
17. Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 2004 ; 82 : 1323-9.
18. Josso N, Belville C, di Clemente N, Picard JY. AMH and AMH receptor defects in persistent Mullerian duct syndrome. Hum Reprod Update 2005 ; 11 : 351-6.
19. Josso N and N Clemente. Transduction pathway of anti-Mullerian hormone, a sex-specific member of the TGF-beta family. Trends Endocrinol Metab 2003 ; 14 : 91-7.
20. Josso N, di Clemente N, Gouedard L. Anti-Mullerian hormone and its receptors. Mol Cell Endocrinol 2001 ; 179 : 25-32.
21. La Marca A, De Leo V, Giulini S. Anti-Mullerian Hormone in Premenopausal Women and After Spontaneous or Surgically Induced Menopause. J Soc Gynecol Investig 2005 ; 12 : 545-8.
22. La Marca A, Orvieto R, Giulini S, Jasonni VM, Volpe A, De Leo V. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril 2004 ; 82 : 970-2.
23. Lansac J, Guérif F. L'assistance médicale à la procréation en pratique, In : L'Assistance Médicale à la Procréation, éd. Masson, Paris, 2005, pp. 1-7.
24. Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004 ; 89 : 318-23.
25. Lee MM, Misra M, Donahoe PK, MacLauglin DT. MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol Cell Endocrinol 2003 ; 211 : 91-8.
26. Long WQ, Ranchin V, Pautier P et al. Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 2000 ; 85 : 540-4.
27. Lutchman Singh K, Davies M, Chatterjee R. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update 2005 ; 11 : 69-89.
28. Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? Bjog 2005 ; 112 : 1384-90.
29. Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients? Bjog 2004 ; 111 : 1248-53.
30. Nakhuda GS, Chu MC, Wang JG, Sauer MV, Lobo RA. Elevated serum mullerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization. Fertil Steril 2006 ; 85 : 1541-3
31. Penarrubia J, Fabregues F, Manau D et al. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Hum Reprod 2005 ; 20 : 915-22.
32. Picard JY and C Belville. Genetics and molecular pathology of anti-Mullerian hormone and its receptor. J Soc Biol 2002 ; 196 : 217-21.
33. Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 2006 ; 91 : 941-5.
34. Pigny P, Merlen E, Robert Y et al. Elevated serum level of antimullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003 ; 88 : 5957-62.
35. Rey R, Lukas-Croisier C, Lasala C, Bedecarras P. AMH/MIS: what we know already about the gene, the protein and its regulation. Mol Cell Endocrinol 2003 ; 211 : 21-31.
36. Rey R and JY Picard. Embryology and endocrinology of genital development. Baillieres Clin Endocrinol Metab 1998 ; 12 : 17-33.
37. Rey R, JC Sabourin, Venara M et al. Anti-Mullerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Hum Pathol 2000 ; 31 : 1202-8.
38. Salhi I, Cambon-Roques S, Lamarre I et al. The anti-Mullerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand. Biochem J 2004 ; 379 : 785-93.
39. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002 ; 77 : 468-71.
40. Silberstein T, MacLaughlin DT, Shai I et al. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod 2006 ; 21 : 159-63.
41. Teixeira J, Fynn-Thompson E, Payne AH et al. Mullerian-inhibiting substance regulates androgen synthesis at the transcriptional level. Endocrinology 1999 ; 140 : 4732-8.
42. Teixeira J, Maheswaran S, Payne AH, Donahoe PK. Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev 2001 ; 22 : 657-74.
43. Themmen AP. Anti-Mullerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker. J Natl Cancer Inst Monogr 2005 ; 34 : 18-21.
44. van Rooij IA, Broekmans FJ, Scheffer GJ et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005 ; 83 : 979-87.
45. van Rooij IA, Broekmans FJ, te Velde ER et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002 ; 17 : 3065-71.
46. van Rooij IA, Tonkelaar I, Broekmans FJ et al. Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004 ; 11 : 601-6.
47. Visser JA. AMH signaling: from receptor to target gene. Mol Cell Endocrinol 2003 ; 211 : 65-73.
48. Visser JA and AP Themmen. Anti-Mullerian hormone and folliculogenesis. Mol Cell Endocrinol 2005 ; 234 : 81-6.
49. Xavier F and S Allard. Anti-Mullerian hormone, beta-catenin and Mullerian duct regression. Mol Cell Endocrinol 2003 ; 211 : 115-21.